Researchers at the University of Essex have found new biochemical indicators of cirrhosis in blood plasma which could help detect the disease in its early stages.
The findings of the project, which was led by Professor Paul Thornalley, of the Disease Mechanisms and Therapeutics Research Group in the Department of Biological Sciences, suggest these markers could be used to assess damage to the liver and the likelihood of developing cirrhosis which could have a significant effect on choosing appropriate therapy.
Cirrhosis is scarring of the liver involving the formation of fibrous (scar) tissue. There is severe impairment of liver function in the advanced state but recent advances in drug development have led to the view that fibrosis may in the future become reversible.
Kate Cleveland | alfa
Routing gene therapy directly into the brain
07.12.2017 | Boston Children's Hospital
New Hope for Cancer Therapies: Targeted Monitoring may help Improve Tumor Treatment
01.12.2017 | Berliner Institut für Gesundheitsforschung / Berlin Institute of Health (BIH)
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
11.12.2017 | Physics and Astronomy
11.12.2017 | Earth Sciences
11.12.2017 | Information Technology